Abstract
Fuchs' heterochromic cyclitis (FHC) is an important diagnosis to make. Not only for the patient, because incorrect diagnosis may lead to unnecessary therapy and the failure to detect secondary glaucoma, but also for the comparison of studies on the etiology of FHC, which is still unknown. No clinical criteria for establishing the diagnosis of FHC have been internationally accepted yet. By means of clinical analyses of FHC patients in different parts of the world, predominant clinical features may be distinguished and combined to form (internationally accepted) diagnostic criteria. We report a clinical analysis of 51 FHC patients in the Netherlands. Acute symptoms (severe redness, pain or photophobia) were never (100%) encountered. Characteristic keratic precipitates (88%) and/or minimal aqueous cells and flare (60%) and/or vitreous opacities (84%) were major signs, indicating a chronic inflammatory activity, in which no synechiae (100%) were present. Heterochromia (82%) was not a constant sign, but iris stromal atrophy, which causes the heterochromia, was always present (100%). Cataract was present in 82% as a result of the chronic iridocyclitis. Secondary glaucoma was present in 22%. Based on the predominant clinical findings obtained from this analysis of FHC patients, and on data in the literature, we propose clinical diagnostic criteria for FHC. Future studies, also including other uveitis groups, are necessary to confirm these diagnostic criteria.
Similar content being viewed by others
Abbreviations
- FHC:
-
Fuchs' heterochromic cyclitis
References
Fuchs E. Über Komplikationen der Heterochromie. Z Augenheilk. 1906; 159: 191–212.
Kimura SJ, Hogan MJ, Thygeson P. Fuchs' syndrome of heterochromic cyclitis. Arch Ophthalmol 1955; 54: 179–86.
Dernouchamps JP. Fuchs' heterochromic cyclitis: an IUSG study about 550 cases. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier Science Publishers, 1984: 129–35.
Tabbut BR, Howard HT, Williams D. Fuchs' heterochromic iridocyclitis in blacks. Arch Ophthalmol 1988; 106: 1688–90.
Silva HF, Orefice F, Pinheiro SRA. Fuchs' heterochromic cyclitis: clinical study of 132 cases. In: Belfort Jr R, Petrilli AMN, Nussenblatt R, eds. Proceedings first world uveitis symposium, Guaruja, Sao Paulo, Brazil. March 1988. Sao Paulo: Livraria Roca, 1989: 215–22.
Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I: Anterior uveitis; II: Classification of the posterior manifestations of uveitis. Am J Ophthalmol 1959; 47: 155–76.
Chylack LT, Leske CM, Sperduto R, Khu P, McCarthy D. The Lens Opacities Casecontrol Study Group. Lens Opacities Classification System. Arch Ophthalmol 1988; 106: 330–34.
Panek WC, Holland GN, Lee DA, Chritensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol 1990; 74: 223–27.
Liesegang TJ. Clinical features and prognosis in Fuchs' uveitis syndrome. Arch Ophthalmol 1982; 100: 1623–26.
O'Connor GR. Doyne lecture: Heterochromic iridocyclitis. Trans Ophthalmol Soc UK 1985; 104: 219–31.
Baarsma GS, de Vries J, Hammudoglu D. Extracapsular catract extraction with posterior chamber lens implantation in Fuchs' heterochromic cyclitis. Br J Ophthalmol 1991; 75: 306–8.
De Abreu ML, Belfort R, Hirata PS. Fuchs' heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol 1982; 93: 739–44.
Arffa RC, Schlaegel TF. Chorioretinal scars in Fuchs' heterochromic iridocyclitis. Arch Ophthalmol 1984; 102: 1153–55.
Loewenfeld IE, Thompson, HS. Fuchs's heterochromic cyclitis: a critical review of the literature, I: Clinical characteristics of the syndrome. Surv Ophthalmol 1973; 17: 396–457. II: Etiology and mechanisms. Surv Ophthalmol 1973; 18: 2-61.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
La Hey, E., Baarsma, G.S., De Vries, J. et al. Clinical analysis of Fuchs' heterochromic cyclitis. Doc Ophthalmol 78, 225–235 (1991). https://doi.org/10.1007/BF00165685
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165685